Patents on Pot? U.S. Lawsuit Puts Cannabis Claims to the Test

In October, the U.S. government issued Axim Biotechnologies Inc a patent for a cannabis-based suppository to treat irritable bowel syndrome.

Britain’s GW Pharmaceuticals Plc, which recently brought to market a drug derived from marijuana for epilepsy, is now seeking patent protection for another one to treat eczema.

With marijuana now fully legal in Canada and at least partially legalized in the majority of U.S. states, companies are rushing to patent new formulations of the age-old botanical.  Continue reading “Patents on Pot? U.S. Lawsuit Puts Cannabis Claims to the Test”

Has The U.S. Reached A ‘Tipping Point’ In Marijuana Legalization?

Has the U.S. reached the “tipping point” in marijuana legalization? That’s what one CNN commentator said happened last month when, on June 26, Oklahoma adopted medical marijuana through a ballot initiative — making it the 30th state to do so, as you can see in the figure below. Continue reading “Has The U.S. Reached A ‘Tipping Point’ In Marijuana Legalization?”